In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci-Reference-Cited by-同舟云学术

In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci

Published:2011-03 Issue:3 Volume:69 Page:275-279
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Farrell David J.,Krause Kevin M.,Benton Bret M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates;Bell;J. Clin. Microbiol.,1998

2. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998–1999;Bell;Antimicrob. Agents Chemother.,2002

3. M7-A7: Methods for dilution of Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved standard - Seventh edition;CLSI,2006

4. Vancomycin resistance in gram-positive cocci;Courvalin;Clin. Infect. Dis.,2006

5. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States;Draghi;Antimicrob. Agents Chemother.,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains;Antimicrobial Agents and Chemotherapy;2017-02

2. Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia;Expert Opinion on Drug Metabolism & Toxicology;2016-05-30

3. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections;Future Microbiology;2015-08

4. Telavancin In Vitro Activity against a Collection of Methicillin-Resistant Staphylococcus aureus Isolates, Including Resistant Subsets, from the United States;Antimicrobial Agents and Chemotherapy;2015-03

5. Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus;Clinical Infectious Diseases;2014-12-03